Log In
BCIQ
Print this Print this
 

granisetron

  Manage Alerts
Collapse Summary General Information
Company Almac Group Ltd.
DescriptionSerotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationEmesis
Indication DetailsTreat chemotherapy induced nausea and vomiting (CINV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today